A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Effect of Nystatin on the Development of Oral Irritation in Patients Receiving High-Dose Intravenous Interleukin-2

A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Effect of Nystatin on the Development of Oral Irritation in Patients Receiving High-Dose Intravenous Interleukin-2 is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID11449076

P50authorSteven RosenbergQ2347448
Francesco MarincolaQ107723823
P2093author name stringSeth M. Steinberg
Claudia A. Seipp
Frank G. Witebsky
Galen A. Ohnmacht
Giao Q. Phan
Kathleen E. Morton
Linda J. Rogers-Freezer
Lori S. McIntyre
Paula M. Muehlbauer
Rose S. Goodwin
Sharon A. Mavroukakis
Yvonne R. Shea
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectinterleukinsQ194908
nystatinQ251005
placeboQ269829
placebo-controlled trialQ108853737
P304page(s)188-192
P577publication date2001-03-01
P1433published inJournal of immunotherapy : official journal of the Society for Biological TherapyQ27709769
P1476titleA Prospective, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Effect of Nystatin on the Development of Oral Irritation in Patients Receiving High-Dose Intravenous Interleukin-2
P478volume24

Search more.